Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation reports developments tied to its role as a diversified healthcare services company and major pharmaceutical distributor. Company news commonly covers fiscal results and guidance, dividend declarations, capital allocation, share repurchase activity, and updates across core distribution, oncology and multispecialty, biopharma services, pharmacy technology, and medical-surgical product categories.
McKesson updates also include portfolio actions and governance changes. Recent company materials document the completed divestiture of its Norwegian retail and distribution businesses, marking its exit from European operations, alongside recurring communications about earnings events, healthcare conferences, and leadership succession matters.
McKesson Corporation (NYSE: MCK) is set to release its fourth-quarter and full-year fiscal 2023 financial results after market close on Monday, May 8, 2023. A live webcast of the earnings conference call will be held at 4:30 PM Eastern Time to discuss the financial outcomes. Investors can access the webcast on McKesson’s Investor Relations website, where the earnings release and supporting materials will also be available. McKesson is a leader in healthcare services, dedicated to improving health outcomes and partnering with various stakeholders to enhance the accessibility and affordability of quality care.
McKesson Medical-Surgical Government Solutions LLC, based in Richmond, Va., has been awarded a five-year contract by the U.S. Department of Veterans Affairs for Federal Supply Schedule 65 II A. This contract allows greater access to McKesson’s medical supplies, including respiratory accessories and surgical instruments. According to Deborah Haywood, VP of Government Solutions, this milestone enhances McKesson’s ability to positively impact patient outcomes and create cost efficiencies in healthcare. The inclusion on the FSS facilitates expansion in providing high-quality medical supplies to federal customers, especially for veterans and the military community.
McKesson Corporation (NYSE: MCK) has announced its financial results for the third quarter of fiscal 2023. The detailed results are accessible on McKesson's Investor Relations website. A live webcast to discuss these results is scheduled for February 1st at 4:30 PM ET. McKesson is recognized as a leader in healthcare services, focusing on enhancing health outcomes through partnerships with various stakeholders, including biopharma companies and care providers. For additional insights about the company's impact in healthcare, visit McKesson.com.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share of common stock. This dividend will be payable on April 3, 2023, to stockholders of record as of March 1, 2023. McKesson is a leader in diversified healthcare services, committed to enhancing health outcomes by collaborating with various stakeholders in the healthcare ecosystem.
McKesson Corporation (NYSE: MCK) will announce its third-quarter fiscal 2023 financial results on February 1, 2023, after market close. Investors can join a live webcast at 4:30 PM Eastern Time to discuss the results. The webcast will be accessible through McKesson's Investor Relations website, where the earnings release and financial documents will also be available. McKesson is a leader in healthcare services, partnering with various stakeholders to enhance healthcare access and affordability.
McKesson Corporation (NYSE: MCK) has announced its fiscal 2023 second-quarter financial results, which are available on their Investor Relations website. A live webcast for investors will be held on November 1 at 4:30 PM ET to discuss these results. McKesson, a leader in healthcare services, is committed to enhancing health outcomes for patients by collaborating with various healthcare stakeholders. For more information on McKesson's financials and upcoming events, please visit their Investor Relations site.
The Board of Directors of McKesson Corporation (NYSE:MCK) declared a regular dividend of 54 cents per share. This dividend is set to be paid on January 3, 2023, to stockholders of record as of December 1, 2022. McKesson, a leader in healthcare services, aims to improve health outcomes by collaborating with various stakeholders in the healthcare ecosystem.
McKesson Corporation (NYSE: MCK) announced an extension of its partnership with CVS Health to distribute pharmaceuticals through June 2027. This partnership, which has lasted over 20 years, aims to improve health outcomes for patients. Additionally, McKesson will release its second-quarter fiscal 2023 earnings results on November 1, 2022, with a conference call scheduled at 4:30 PM Eastern Time. The live webcast will be accessible through McKesson's Investor Relations website.
McKesson Corporation (NYSE:MCK) has announced the acquisition of Rx Savings Solutions for up to $875 million to enhance access, affordability, and adherence solutions for patients. The deal includes a $600 million upfront payment and an additional $275 million contingent on RxSS's performance through 2025. This acquisition aims to strengthen McKesson's ecosystem, leveraging RxSS's technology in reducing prescription costs and enhancing patient medication adherence. The acquisition is expected to close in the second half of Fiscal 2023.
McKesson Corporation (NYSE:MCK) has announced the appointment of LeAnn B. Smith as the new executive vice president and chief human resources officer (CHRO), effective December 1, 2022. She will succeed Tracy L. Faber, who is retiring after 11 years. Smith, who joined McKesson in 2021, will oversee all human resources functions, focusing on talent management, diversity, and organizational change. CEO Brian Tyler expressed confidence in Smith's capabilities, highlighting her extensive experience, including a previous role at Walmart.